349 related articles for article (PubMed ID: 29796876)
1. De novo FBXO11 mutations are associated with intellectual disability and behavioural anomalies.
Fritzen D; Kuechler A; Grimmel M; Becker J; Peters S; Sturm M; Hundertmark H; Schmidt A; Kreiß M; Strom TM; Wieczorek D; Haack TB; Beck-Wödl S; Cremer K; Engels H
Hum Genet; 2018 May; 137(5):401-411. PubMed ID: 29796876
[TBL] [Abstract][Full Text] [Related]
2. De Novo Variants in the F-Box Protein FBXO11 in 20 Individuals with a Variable Neurodevelopmental Disorder.
Gregor A; Sadleir LG; Asadollahi R; Azzarello-Burri S; Battaglia A; Ousager LB; Boonsawat P; Bruel AL; Buchert R; Calpena E; Cogné B; Dallapiccola B; Distelmaier F; Elmslie F; Faivre L; Haack TB; Harrison V; Henderson A; Hunt D; Isidor B; Joset P; Kumada S; Lachmeijer AMA; Lees M; Lynch SA; Martinez F; Matsumoto N; McDougall C; Mefford HC; Miyake N; Myers CT; Moutton S; Nesbitt A; Novelli A; Orellana C; Rauch A; Rosello M; Saida K; Santani AB; Sarkar A; Scheffer IE; Shinawi M; Steindl K; Symonds JD; Zackai EH; ; ; Reis A; Sticht H; Zweier C
Am J Hum Genet; 2018 Aug; 103(2):305-316. PubMed ID: 30057029
[TBL] [Abstract][Full Text] [Related]
3. De novo variants in FBXO11 cause a syndromic form of intellectual disability with behavioral problems and dysmorphisms.
Jansen S; van der Werf IM; Innes AM; Afenjar A; Agrawal PB; Anderson IJ; Atwal PS; van Binsbergen E; van den Boogaard MJ; Castiglia L; Coban-Akdemir ZH; van Dijck A; Doummar D; van Eerde AM; van Essen AJ; van Gassen KL; Guillen Sacoto MJ; van Haelst MM; Iossifov I; Jackson JL; Judd E; Kaiwar C; Keren B; Klee EW; Klein Wassink-Ruiter JS; Meuwissen ME; Monaghan KG; de Munnik SA; Nava C; Ockeloen CW; Pettinato R; Racher H; Rinne T; Romano C; Sanders VR; Schnur RE; Smeets EJ; Stegmann APA; Stray-Pedersen A; Sweetser DA; Terhal PA; Tveten K; VanNoy GE; de Vries PF; Waxler JL; Willing M; Pfundt R; Veltman JA; Kooy RF; Vissers LELM; de Vries BBA
Eur J Hum Genet; 2019 May; 27(5):738-746. PubMed ID: 30679813
[TBL] [Abstract][Full Text] [Related]
4. Whole exome sequencing is necessary to clarify ID/DD cases with de novo copy number variants of uncertain significance: Two proof-of-concept examples.
Giorgio E; Ciolfi A; Biamino E; Caputo V; Di Gregorio E; Belligni EF; Calcia A; Gaidolfi E; Bruselles A; Mancini C; Cavalieri S; Molinatto C; Cirillo Silengo M; Ferrero GB; Tartaglia M; Brusco A
Am J Med Genet A; 2016 Jul; 170(7):1772-9. PubMed ID: 27108886
[TBL] [Abstract][Full Text] [Related]
5. Three intellectual disability-associated de novo mutations in MECP2 identified by trio-WES analysis.
Gu Y; Xiang B; Zhu L; Ma X; Chen X; Cai T
BMC Med Genet; 2020 May; 21(1):99. PubMed ID: 32393352
[TBL] [Abstract][Full Text] [Related]
6. The first familial case of inherited intellectual developmental disorder with dysmorphic facies and behavioral abnormalities (IDDFBA) with a novel FBXO11 variant.
Lee CG; Seol CA; Ki CS
Am J Med Genet A; 2020 Nov; 182(11):2788-2792. PubMed ID: 32902151
[TBL] [Abstract][Full Text] [Related]
7. CNV analysis using whole exome sequencing identified biallelic CNVs of VPS13B in siblings with intellectual disability.
Enomoto Y; Tsurusaki Y; Yokoi T; Abe-Hatano C; Ida K; Naruto T; Mitsui J; Tsuji S; Morishita S; Kurosawa K
Eur J Med Genet; 2020 Jan; 63(1):103610. PubMed ID: 30602132
[TBL] [Abstract][Full Text] [Related]
8. Biallelic ZNF407 mutations in a neurodevelopmental disorder with ID, short stature and variable microcephaly, hypotonia, ocular anomalies and facial dysmorphism.
Zahra Q; Çakmak Ç; Koprulu M; Shuaib M; Sobreira N; Kalsner L; Sobreira J; Guillen Sacoto MJ; Malik S; Tolun A
J Hum Genet; 2020 Dec; 65(12):1115-1123. PubMed ID: 32737394
[TBL] [Abstract][Full Text] [Related]
9. A case of severe TBCE-negative hypoparathyroidism-retardation-dysmorphism syndrome: Case report and literature review.
Ryabets-Lienhard A; Issaranggoon Na Ayuthaya S; Graham JM; Pitukcheewanont P
Am J Med Genet A; 2018 Aug; 176(8):1768-1772. PubMed ID: 30055029
[TBL] [Abstract][Full Text] [Related]
10. Intellectual disability associated with craniofacial dysmorphism, cleft palate, and congenital heart defect due to a de novo MEIS2 mutation: A clinical longitudinal study.
Gangfuß A; Yigit G; Altmüller J; Nürnberg P; Czeschik JC; Wollnik B; Bögershausen N; Burfeind P; Wieczorek D; Kaiser F; Roos A; Kölbel H; Schara-Schmidt U; Kuechler A
Am J Med Genet A; 2021 Apr; 185(4):1216-1221. PubMed ID: 33427397
[TBL] [Abstract][Full Text] [Related]
11. Analysis of 31-year-old patient with SYNGAP1 gene defect points to importance of variants in broader splice regions and reveals developmental trajectory of SYNGAP1-associated phenotype: case report.
Prchalova D; Havlovicova M; Sterbova K; Stranecky V; Hancarova M; Sedlacek Z
BMC Med Genet; 2017 Jun; 18(1):62. PubMed ID: 28576131
[TBL] [Abstract][Full Text] [Related]
12. De novo variants in CDK13 associated with syndromic ID/DD: Molecular and clinical delineation of 15 individuals and a further review.
van den Akker WMR; Brummelman I; Martis LM; Timmermans RN; Pfundt R; Kleefstra T; Willemsen MH; Gerkes EH; Herkert JC; van Essen AJ; Rump P; Vansenne F; Terhal PA; van Haelst MM; Cristian I; Turner CE; Cho MT; Begtrup A; Willaert R; Fassi E; van Gassen KLI; Stegmann APA; de Vries BBA; Schuurs-Hoeijmakers JHM
Clin Genet; 2018 May; 93(5):1000-1007. PubMed ID: 29393965
[TBL] [Abstract][Full Text] [Related]
13. Loss-of-function variants of SETD5 cause intellectual disability and the core phenotype of microdeletion 3p25.3 syndrome.
Kuechler A; Zink AM; Wieland T; Lüdecke HJ; Cremer K; Salviati L; Magini P; Najafi K; Zweier C; Czeschik JC; Aretz S; Endele S; Tamburrino F; Pinato C; Clementi M; Gundlach J; Maylahn C; Mazzanti L; Wohlleber E; Schwarzmayr T; Kariminejad R; Schlessinger A; Wieczorek D; Strom TM; Novarino G; Engels H
Eur J Hum Genet; 2015 Jun; 23(6):753-60. PubMed ID: 25138099
[TBL] [Abstract][Full Text] [Related]
14. Clinical features associated with CTNNB1 de novo loss of function mutations in ten individuals.
Kharbanda M; Pilz DT; Tomkins S; Chandler K; Saggar A; Fryer A; McKay V; Louro P; Smith JC; Burn J; Kini U; De Burca A; FitzPatrick DR; Kinning E;
Eur J Med Genet; 2017 Feb; 60(2):130-135. PubMed ID: 27915094
[TBL] [Abstract][Full Text] [Related]
15. Further delineation of the phenotype caused by biallelic variants in the WDR4 gene.
Trimouille A; Lasseaux E; Barat P; Deiller C; Drunat S; Rooryck C; Arveiler B; Lacombe D
Clin Genet; 2018 Feb; 93(2):374-377. PubMed ID: 28617965
[TBL] [Abstract][Full Text] [Related]
16. DYRK1A mutations in two unrelated patients.
Ruaud L; Mignot C; Guët A; Ohl C; Nava C; Héron D; Keren B; Depienne C; Benoit V; Maystadt I; Lederer D; Amsallem D; Piard J
Eur J Med Genet; 2015 Mar; 58(3):168-74. PubMed ID: 25641759
[TBL] [Abstract][Full Text] [Related]
17. The DYRK1A gene is a cause of syndromic intellectual disability with severe microcephaly and epilepsy.
Courcet JB; Faivre L; Malzac P; Masurel-Paulet A; Lopez E; Callier P; Lambert L; Lemesle M; Thevenon J; Gigot N; Duplomb L; Ragon C; Marle N; Mosca-Boidron AL; Huet F; Philippe C; Moncla A; Thauvin-Robinet C
J Med Genet; 2012 Dec; 49(12):731-6. PubMed ID: 23099646
[TBL] [Abstract][Full Text] [Related]
18. A de novo mutation in RPL10 causes a rare X-linked ribosomopathy characterized by syndromic intellectual disability and epilepsy: A new case and review of the literature.
Bourque DK; Hartley T; Nikkel SM; Pohl D; Tétreault M; Kernohan KD; ; Dyment DA
Eur J Med Genet; 2018 Feb; 61(2):89-93. PubMed ID: 29066376
[TBL] [Abstract][Full Text] [Related]
19. Identification of an individual with a SYGNAP1 pathogenic mutation in India.
Verma V; Mandora A; Botre A; Clement JP
Mol Biol Rep; 2020 Nov; 47(11):9225-9234. PubMed ID: 33090308
[TBL] [Abstract][Full Text] [Related]
20. Expanding the phenotype of intellectual disability caused by HIVEP2 variants.
Goldsmith H; Wells A; Sá MJN; Williams M; Heussler H; Buckman M; Pfundt R; de Vries BBA; Goel H
Am J Med Genet A; 2019 Sep; 179(9):1872-1877. PubMed ID: 31207095
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
